Centre Hospitalier Intercommunal Toulon / La Seine-Sur-Mer — Clinical Trial Site

68 Registered trials

32 Currently recruiting

Organisation

Centre Hospitalier Intercommunal Toulon / La Seine-Sur-Mer

Location

Toulon, France

Identifier

ORG-100044066

Address

54 Rue Henri Sainte Claire Deville, Cs 91400, 83056, France

Departments

-
83
Cardiologie
Cardiology
Centre Hospitalier Intercommunal Toulon La Seine- Sur-Mer
CHITS - Hôpital Sainte Musse Service d'Oncologie
Délégation à la Recherche Clinique et à l'Innovation
Dermatology
gastroenterology
Gynécologie-Obstétrique
Hématologie
Hépatogastroentérologie
ICU
Médecine Vasculaire
Medical onclogy
Medical Oncology
N/A
NA
NEONATOLOGIE
Onco-hematologie
Oncologie
Oncology
Oncology Department
Ophtalmologie
Pneumologie
Pneumologie et d’oncologie thoracique
Pneumology
pneumology oncology
Pôle Cardiovasculaire, Département de Cardiologie
Psychiatry
Réanimation
Réanimation polyvalente
Service consultations, exploration de cardiologie
Service d'Oncologie
Service d'oncologie pneumologie
Service d’Oncologie
Service de Cardiologie
Service de médecine vasculaire et médecine interne
Service de Pneumologie
Service de réanimation polyvalente
Service Oncologie
Service Pneumologie
Vascular

Clinical trials at this site (68)

Search interface

Randomized trial of avelumab-cetuximab-Radiotherapy versus standards of care in the head and neck cancers Ended

2024-513964-24-00 Squamous cell carcinoma, previously untreated Stage III 5 2017-09-14
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lun… Ended

2023-505981-26-00 Non−Small Cell Lung Cancer 5 2015-11-20
Chemotherapy or chemotherapy + hormonotherapy in women over 70 with HER2 receptor-negative but estrogen receptor-positive breast cancer acco… Ended

2024-516996-34-00 oestrogen-receptor (ER)-positive HER2-negative breast c 5 2012-04-12
Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients Ended

2024-515171-35-00 Prostatic adenocarnicoma with high risk of recurrence 5 2011-07-06
A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in … Ended

2024-511057-22-00 Major Depressive Disorder (MDD) with Moderate-to-severe 5 2024-12-04
A study to learn if baxdrostat works at reducing blood pressure and is safe in people with high blood pressure Ended

2023-505499-32-00 Uncontrolled hypertension (uTHN) defined as blood press 5 2024-03-08
A study to learn more about how well BAY 3018250 works and how safe it is for people with proximal deep vein thrombosis Ended

2023-503315-15-00 Thrombolysis of symptomatic proximal vein thrombosis 4 2023-12-20
COTRIVAP - Efficacy of cotrimoxazole as a de-escalation treatment of Ventilator-Associated Pneumonia in intensive care unit Ended

2023-505108-52-00 Intensive Care 5 2023-12-20
Phase 2 Study of MORAb-202 in Previously Treated Metastatic NSCLC AC Ended

2023-504112-15-00 Metastatic Non-Small Cell Lung Cancer 4 2023-01-04
Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN High Risk, Cisplatin-ineligible Participants (XRAY VISION) Ended

2023-508528-36-00 Resected squamous cell carcinoma of the head and neck 5 2022-12-16
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24
A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to dalteparin … Ended

2024-513992-42-00 venous thromboembolism (VTE) in patients with gastroint 10 2022-09-13
A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to apixaban on… Ended

2023-509569-19-00 venous thromboembolism (VTE) 10 2022-08-10
A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) Ended

2022-500881-80-00 Chronic Heart Failure With Reduced Ejection Fraction 5 2021-10-29
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants wit… Ended

2023-508443-40-00 Lung Cancer, Non-Small Cell 5 2020-12-18
Adjunctive DobutAmine in sePtic cardiomyopathy with Tissue hypoperfusion: a randomized controlled multi-center trial Ended

2024-517839-50-00 sepsis 11 2020-09-20
A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Ri… Ended

2023-504036-17-00 Chronic Lymphocytic Leukemia (CLL) 5 2020-05-07
Trial comparing the continuation of nivolumab and ipilimumab (doublet immunotherapy) to observation after a first 6 months treatment by nivo… Ended

2024-514586-20-01 Non small cell lung cancer 5 2018-05-02
A Phase III Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant MEDI4736 in Completely Resected Non-Small Cell Lung Can… Ended

2024-517856-36-00 Completely resected primary stage IB (≥ 4cm), II and II 5 2015-03-09
A Study to Compare the Efficacy and Safety of a Combined Regimen of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) Versus Obinutuzumab and … Ended

2023-504034-22-00 Chronic Lymphocytic Leukemia (CLL) 5 2014-12-18